Not a bad result . I would have loved to see them beat the best standard treatment on the first try , but it looks like more work is needed regarding compound strength . The cream they used in the trial was .01 strength . For the phase 2 the trial design will no doubt be different also . It would be nice if they could skip the mild psoriasis and go right into a trial on cronic psoriasis where it has shown to be effective .
Guess I have been spoiled by the first up spectacular success of the cancer trial .
Cheers
SBP
solbec pharmaceuticals limited
Not a bad result . I would have loved to see them beat the best...
Add to My Watchlist
What is My Watchlist?